Rising incidence of cancer to drive the market


The global high potency active pharmaceutical ingredients (APIs) market was valued at $14.4 billion in 2016 and is expected to grow at a CAGR of 10.3 percent over the forecast period, according to a report by Grand View Research Inc. Highly potent APIs are capable of targeting diseased cell selectively and more precisely than other compounds. Increasing incidence of cancer resulted in increasing R&D pertaining to anticancer drugs which thereby propelling the demand for HPAPIs over the forecast period. The rising number of biotech & pharmaceutical industry and increasing investments. Read more

 

In pharmaceutical continuous manufacturing technology, active ingredients are produced in compact, closed units, leveraging automation. Hence, it requires fewer manual interventions. Production steps carried out sequentially in a classic batch process are combined in a continuous process. All these help to bring about continued utilization of production capacity. This, in turn, serves to reduce fluctuations in production, improve yields, and lower costs of operation and equipment. On account of such advantages, the method is seeing fast adoption, according to a report by Transparency Market ResearchRead more

 

Arlanxeo said that its bio-based EPDM rubber is used in the Adidas soccer ball of the World Cup 2018. The EPDM rubber (ethylene-propylene-diene monomer) Keltan Eco 6950 is the rubber basis for a sponge rubber layer directly underneath the “Telstar 18” ball’s outer cover. It serves as a moldable cushion for the ball and supports optimal bounce characteristics during games. Materials that are used in this layer must meet strict requirements in properties such as density, hardness and weight, and they must also demonstrate good processability. The most important performance characteristic, however, is the elasticity and resilience of the layer. Read more

 

Airgas USA LLC, an Air Liquide company said that it plans to build a new air separation unit (ASU) in Mebane, North Carolina. The facility will increase Airgas’ production capabilities in North Carolina’s research triangle area while also strengthening its East Coast merchant gases network. The new facility is expected to be on-stream in 2019 and will produce oxygen, nitrogen and argon for use in customer applications such as metal fabrication, blanketing and purging, combustion, chilling and freezing. In addition, the ASU will produce medical grade oxygen to supply to hospitals. Read more

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s